The global stem cell therapy market is poised for remarkable growth, with revenues projected to escalate from USD 394.50 million in 2024 to USD 2,612.92 million by 2033, reflecting a compelling ...

The Basant Utsav continues to be a cherished cultural celebration, bringing together the people of Panchkula to welcome ...

Virtuozzo offers an alternative to traditional virtualisation platforms, delivering operational efficiency and ...

The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million in 2023, is forecasted to grow at a robust ...

The Scarborough Campus Students’ Union (SCSU) is currently holding elections for next year’s executive team. UTSC students ...

WuXi Biologics passes GMP inspection by Japan PMDA for its drug substance facilities in Wuxi city: Wuxi, China Friday, February 28, 2025, 15:00 Hrs [IST] WuXi Biologics (WuXi Bio) ...

Recent Business Highlights Zerlasiran for Cardiovascular Disease Received positive regulatory feedback from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and the ...

SLN ("Silence" or "the Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection by Japan's ...

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that Jim Corbett, Chief Executive Officer, will ...

Detailed price information for Avita Medical Inc (RCEL-Q) from The Globe and Mail including charting and trades.